Responding to the radiation threat
Tuesday, March 6, 2012 - 16:30
in Health & Medicine
Berkeley Lab Researchers are developing a promising treatment for safely decontaminating humans exposed to radioactive actinides from a major radiation exposure event, such as a nuclear reactor accident or a "dirty bomb" terrorist attack. The treatment, which can be administered as a pill that can result in the excretion of approximately 90-percent of the actinide contaminants within 24 hours, has been advanced through the initial pre-clinical phases.